Cargando…

Application of mesenchymal stem cells as a vehicle to deliver replication-competent adenovirus for treating malignant glioma

Although gene therapy was regarded as a promising approach for glioma treatment, its therapeutic efficacy was often disappointing because of the lack of efficient drug delivery systems. Mesenchymal stem cells (MSCs) have been reported to have a tropism for brain tumors and thus could be used as deli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hai, Cui, Jin, Yong-Min, Jin, Wen-Biao, Han, Zhe-Zhu, Cui, Mei-Nv, Piao, Xue-Zhe, Shen, Xiong-Hu, Zhang, Song-Nan, Sun, Hong-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sun Yat-sen University Cancer Center 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777524/ https://www.ncbi.nlm.nih.gov/pubmed/22429494 http://dx.doi.org/10.5732/cjc.011.10367

Ejemplares similares

Locally-Delivered T-Cell-Derived Cellular Vehicles Efficiently Track and Deliver Adenovirus Delta24-RGD to Infiltrating Glioma
por: Balvers, Rutger K., et al.
Publicado: (2014)

No more helper adenovirus: production of gutless adenovirus (GLAd) free of adenovirus and replication-competent adenovirus (RCA) contaminants
por: Lee, Dongwoo, et al.
Publicado: (2019)

Development of replication-competent adenovirus based vaccine vectors
por: Abbink, P, et al.
Publicado: (2012)

Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization
por: Maxfield, Lori F., et al.
Publicado: (2015)

Human menstrual blood-derived mesenchymal stem cells as a cellular vehicle for malignant glioma gene therapy
por: Wang, Xiao-Jun, et al.
Publicado: (2017)

Antitumor Activity of TRAIL Recombinant Adenovirus in Human Malignant Glioma Cells
por: Kim, Ki-Uk, et al.
Publicado: (2005)

Development of replication-competent adenovirus for bladder cancer by controlling adenovirus E1a and E4 gene expression with the survivin promoter
por: Seo, Ho Kyung, et al.
Publicado: (2014)

Transgene Expression and Host Cell Responses to Replication-Defective, Single-Cycle, and Replication-Competent Adenovirus Vectors
por: Crosby, Catherine M., et al.
Publicado: (2017)

Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma
por: Kiyokawa, Juri, et al.
Publicado: (2019)

Gp350-anchored extracellular vesicles: promising vehicles for delivering therapeutic drugs of B cell malignancies
por: Xiu, Huiqing, et al.
Publicado: (2022)

Combination of a third generation bisphosphonate and replication-competent adenoviruses augments the cytotoxicity on mesothelioma
por: Jiang, Yuanyuan, et al.
Publicado: (2016)

Generation and Characterization of a Replication-Competent Human Adenovirus Type 55 Encoding EGFP
por: Li, Wei, et al.
Publicado: (2023)

Competing Endogenous RNA Networks in Glioma
por: Cen, Liang, et al.
Publicado: (2021)

Antitumor Activity of Ad-IU2, a Prostate-Specific Replication-Competent Adenovirus Encoding the Apoptosis Inducer, TRAIL
por: Jiménez, Juan Antonio, et al.
Publicado: (2009)

The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells
por: Kim, M, et al.
Publicado: (2003)

Cytotoxic effects of replication-competent adenoviruses on human esophageal carcinoma are enhanced by forced p53 expression
por: Yang, Shan, et al.
Publicado: (2015)

Rapid Construction of a Replication-Competent Infectious Clone of Human Adenovirus Type 14 by Gibson Assembly
por: Pan, Haibin, et al.
Publicado: (2018)

Bovine adenovirus-3 as a vaccine delivery vehicle
por: Ayalew, Lisanework E., et al.
Publicado: (2015)

Adenoviruses as vectors for delivering vaccines to mucosal surfaces
por: Babiuk, L.A, et al.
Publicado: (2000)

Biosafety studies of carrier cells infected with a replication-competent adenovirus introduced by IAI.3B promoter
por: Hamada, Katsuyuki, et al.
Publicado: (2014)

Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas
por: Zhang, Qing, et al.
Publicado: (2018)

Adjusting the Balance between Effective Loading and Vector Migration of Macrophage Vehicles to Deliver Nanoparticles
por: Chang, Ya-Nan, et al.
Publicado: (2013)

Antiviral Effects of Curcumin on Adenovirus Replication
por: Jennings, Morgan R., et al.
Publicado: (2020)

Adenovirus F protein as a delivery vehicle for botulinum B
por: Clapp, Beata, et al.
Publicado: (2010)

A Method to Generate and Rescue Recombinant Adenovirus Devoid of Replication-Competent Particles in Animal-Origin-Free Culture Medium
por: Elahi, Seyyed Mehdy, et al.
Publicado: (2023)

Functionally inactivated dominant viral antigens of human cytomegalovirus delivered in replication incompetent adenovirus type 6 vectors as vaccine candidates
por: Tang, Aimin, et al.
Publicado: (2017)

Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts
por: Geoerger, B, et al.
Publicado: (2003)

Synergistic antitumoral efficacy of a novel replicative adenovirus SG611-PDCD5 and daunorubicin in human leukemic cells
por: Zhou, Ya-Lan, et al.
Publicado: (2018)

Regulation of Human Adenovirus Replication by RNA Interference
por: Nikitenko, N. A., et al.
Publicado: (2015)

Pre-Clinical Evaluation of a Replication-Competent Recombinant Adenovirus Serotype 4 Vaccine Expressing Influenza H5 Hemagglutinin
por: Alexander, Jeff, et al.
Publicado: (2012)

Double-modified oncolytic adenovirus armed with a recombinant interferon-like gene enhanced abscopal effects against malignant glioma
por: Jiang, Shan, et al.
Publicado: (2023)

Genetically Engineered Multilineage-Differentiating Stress-Enduring Cells as Cellular Vehicles against Malignant Gliomas
por: Yamasaki, Tomohiro, et al.
Publicado: (2017)

Adenovirus Fibers as Ultra-Stable Vehicles for Intracellular Nanoparticle and Protein Delivery
por: Kokotidou, Chrysoula, et al.
Publicado: (2022)

Wavefront aberrations and retinal image quality in different lenticular opacity types and densities
por: Wu, Cheng-Zhe, et al.
Publicado: (2017)

Metabolic detection of malignant brain gliomas through plasma lipidomic analysis and support vector machine-based machine learning
por: Zhou, Juntuo, et al.
Publicado: (2022)

A novel bispecific immunotoxin delivered by human bone marrow-derived mesenchymal stem cells to target blood vessels and vasculogenic mimicry of malignant gliomas
por: Zhang, Yonghong, et al.
Publicado: (2015)

Single-dose of a replication-competent adenovirus-vectored vaccine provides sterilizing protection against Rift Valley fever virus challenge
por: Bian, Ting, et al.
Publicado: (2022)

Oncolytic adenoviruses: A thorny path to glioma cure
por: Ulasov, I.V., et al.
Publicado: (2014)

Systemic oncolytic adenovirus delivered in mesenchymal carrier cells modulate tumor infiltrating immune cells and tumor microenvironment in mice with neuroblastoma
por: Franco-Luzón, Lidia, et al.
Publicado: (2020)

Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo
por: Li, Xiaohua, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ssdk03qbcrihb5u0nc144qabt8